AlphaYouSG
Insider selling
Steven Gannon sold $641K of Xenon Pharmaceuticals Inc. (XENE) stock
Steven Gannon, Dir of Xenon Pharmaceuticals Inc. (XENE), sold 10,000 shares of XENE stock worth $641K, per an SEC Form 4 filed Aug 13, 2026.
It was an open-market sale.
The trade happened on Aug 11, 2026, 2 days before it was made public.
XENE has moved -38.3% since the trade date, from $63.22 to $38.99 (Sep 21, 2026 close).
- Traded
- Aug 11, 2026
- Disclosed
- Aug 13, 2026
- Filing delay
- 2 days
- Price since
- -38.3%
- Role
- Dir
- Source
- SEC Form 4
More XENE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.